lobbying_activities: 2688722

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2688722	b0baef5f-68c1-4ba7-a20b-d9d53be7d6d7	Q3	THE RABEN GROUP	61458	BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND)	2021	third_quarter	CHM	Proposals to reform FDA authority and personal care products regulatory system. Legislation that would strengthen supply chain transparency and safety of raw ingredients in cosmetics; ban toxic ingredients linked to harmful impacts on health; full fragrance and flavor ingredient disclosure; and health protections, including a ban on chemicals of concern in products marketed to women of color. Specific bills include the No PFAS in Cosmetics Act (H.R. 3990/S.2047), Safe Cosmetics and Personal Care Products Act, Personal Care Products Safety Act (S.2100); Cosmetic Safety Enhancement Act; and the Natural Cosmetics Act. Funding for Centers for Disease and Control Biomonitoring program and National Health Tracking Network in FY 22 Labor-HHS-Education bill. Proposals to reform the FDA's GRAS standard and food-packaging related legislation, including the Toxic Free Food Act (H.R. 3699), the Preventing Harmful Exposure to Phthalates Act (H.R. 4963/S.2669), and the Food Chemical Reassessment Act of 2021 (H.R. 4694).	HOUSE OF REPRESENTATIVES,SENATE	10000		0	0	2021-10-19T10:07:44.787000-04:00